US EditionAkadeum Life Sciences Lands Major Investment to Fuel Growth in Cell and Gene Therapy
- Akadeum Life Sciences closed a $20 million+ financing round led by Michigan Capital Network in Ann Arbor, Michigan, on June 3, 2025.
- The funding comes shortly after Akadeum introduced a GMP-certified range of products intended to facilitate clinical trials and promote the development of advanced cell therapies.
- Akadeum pioneers flotation-based cell separation and has introduced innovations like scalable negative selection, multiplex separation, and a high-capacity T cell chamber.
- CEO Brandon McNaughton expressed appreciation for their investors’ confidence in advancing a future where transformative cell therapies are widely available, while partners commend Akadeum’s pioneering and disruptive technology.
- The funding will enable Akadeum to expand its commercial activities and assist clients as they advance toward clinical trial stages, reflecting the company's growing traction and increasing collaboration with prominent biopharma partners.
28 Articles
28 Articles
Journal Gazette & Times-Courier
Akadeum Life Sciences Lands Major Investment to Fuel Growth in Cell and Gene Therapy
ANN ARBOR, Mich., June 3, 2025 /PRNewswire/ -- Akadeum Life Sciences, a pioneer in buoyancy-based cell separation technology, today announced the successful close of a $20 million+ financing round. The round was led by Michigan Capital Network, with strong participation…
Akadeum Life Sciences in Ann Arbor Closes on $20M for NexGen Cell Therapies - DBusiness Magazine
Akadeum Life Sciences in Ann Arbor has closed a more than $20 million financing round to scale commercial cell separation operations. // Stock photo Akadeum Life Sciences in Ann Arbor, a pioneer in buoyancy-based cell separation technology, has announced the successful close of a $20 million-plus financing round. The round was led by Michigan Capital Network, with strong participation from Arboretum Ventures, NYBC Ventures, and other investors. …
Akadeum Life Sciences Raises $20M+ in Funding
Akadeum Life Sciences, an Ann Arbor, MI-based company which specializes in buoyancy-based cell separation technology, raised $20M+ in funding. The round was led by Michigan Capital Network, with participation from Arboretum Ventures, NYBC Ventures, and other investors. The company intends to use the funds to scale commercial operations and especially support customers entering clinical trials. […] The post Akadeum Life Sciences Raises $20M+ in F…
Coverage Details
Bias Distribution
- 92% of the sources are Center
To view factuality data please Upgrade to Premium
